{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:07:57Z","timestamp":1760983677049},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/maj.0b013e3181ec063b","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T10:23:19Z","timestamp":1282213399000},"page":"382-384","source":"Crossref","is-referenced-by-count":12,"title":["Reversible Choreoathetosis After the Administration of Ceftriaxone Sodium in Patients With End-Stage Renal Disease"],"prefix":"10.1016","volume":"340","author":[{"given":"Yoshinori","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashio","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harue","family":"Wakasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Wakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1097\/MAJ.0b013e3181ec063b_bb0010","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1177\/089686080802803s30","article-title":"Immune dysfunction in dialysis patients\u2014prevention and treatment strategies","volume":"28","author":"Tranaeus","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0891-5520(05)70152-5","article-title":"Infections associated with uremia and dialysis","volume":"15","author":"Minnaganti","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijantimicag.2003.11.004","article-title":"Mechanisms of antibiotic neurotoxicity in renal failure","volume":"23","author":"Chow","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/00003088-200746120-00003","article-title":"Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy","volume":"46","author":"Pea","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0030","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2165\/00003495-199550050-00005","article-title":"Bacterial meningitis. Practical guidelines for management","volume":"50","author":"Rockowitz","year":"1995","journal-title":"Drugs"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0035","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/14656566.8.10.1493","article-title":"Bacterial meningitis: a review of effective pharmacotherapy","volume":"8","author":"Weisfelt","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0040","first-page":"167","article-title":"Neurotoxicity associated with acyclovir in end stage renal failure","volume":"110","author":"Kitching","year":"1997","journal-title":"N Z Med J"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/pgmj.2004.019356","article-title":"Chorea and related disorders","volume":"80","author":"Bhidayasiri","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0050","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","article-title":"Retrospective review of neurotoxicity induced by cefepime and ceftazidime","volume":"23","author":"Chow","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1592\/phco.26.8.1169","article-title":"Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review","volume":"26","author":"Lams","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0065","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ndt\/gfm713","article-title":"The neurotoxicity and safety of treatment with cefepime in patients with renal failure","volume":"23","author":"Sonck","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jac\/27.4.405","article-title":"Neurotoxicity of \u03b2-lactam antibiotics: predisposing factors and pathogenesis","volume":"27","author":"Schliamser","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0075","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archinte.1994.00420050158014","article-title":"Ceftazidime-related nonconvulsive status epilepticus","volume":"154","author":"Klion","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0080","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.50.6.1873","article-title":"Cefuroxime-induced encephalopathy","volume":"50","author":"Herishanu","year":"1998","journal-title":"Neurology"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bmj.283.6288.409","article-title":"Cephaloridine encephalopathy","volume":"283","author":"Taylor","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0090","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archneur.1988.00520330010002","article-title":"Ceftazidime-induced encephalopathy in a patient with renal impairment","volume":"45","author":"Douglas","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.55.4.333","article-title":"Ceftazidime encephalopathy: absence status and toxic hallucinations","volume":"55","author":"Jackson","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.idc.2004.04.013","article-title":"Use of antibacterial agents in renal failure","volume":"18","author":"Livornese","year":"2004","journal-title":"Infect Dis Clin North Am"},{"key":"10.1097\/MAJ.0b013e3181ec063b_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003088-199222030-00002","article-title":"Clinical pharmacokinetics of antibiotics in patients with impaired renal function","volume":"22","author":"St Peter","year":"1992","journal-title":"Clin Pharmacokinet"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915314506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915314506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T15:03:01Z","timestamp":1636210981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915314506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0002962915314506"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3181ec063b","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}